Program: Bridgehead (Accelerator)

Program targets: high-quality biotech, medtech or digital healthscale-ups with a need to internationalise and scale to new markets. The company has to sell a product or service in at least one market in Europe and be ready to open up a new market and have fewer than 250 full-time employees.

Opportunities: Preparation for international expansion and help companies achieve tangible business results in European or global markets. EIT Health network of incubators, accelerators, and clusters (also referred as Catalysers) is used to achieve the goals. Funding of up to €30,000 for scale-ups aiming at European expansion and €40,000 for SMEs aiming at entering Global markets. Individualised country-specific services – local regulations, connections with industry leaders, manufacturers, producers and distributors, testing and etc.

Selection:
Criteria: Impact of Programme and Clarity of direction, Market Opportunity & Traction, Business Model & Development Strategy, Management Capability, Need to internationalise and expand in Europe, Promising and Credible Scale-up
Submission of applications: till 14 March 2022, 23:59h CET (first intake)
More information: https://eithealth.eu/programmes/bridgehead/
03/03/2022 11 CET time informational webinar will take place: https://eithealth-eu.zoom.us/webinar/register/8916414015904/WN_hc11cqZVSjy1dZ7sE8SjzQ

Deadline for Applications: 2022-03-14